Refractory Celiac Disease: What the Gastroenterologist Should Know

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Oct 16

PMID 39408713

Authors

Mariana Verdelho Machado

Affiliations

Soon will be listed here.

Abstract

Fewer than 1% of patients with celiac disease (CD) will develop refractory CD (RCD). As such, most gastroenterologists might never need to manage patients with RCD. However, all gastroenterologists must be familiarized with the basic concepts of RCD and non-responsive CD (NRCD), since it can present as a severe disease with high mortality, not only due to intestinal failure, but also due to progression to enteropathy-associated T cell lymphoma (EATL) and a higher susceptibility to life-threatening infections. The diagnostic workup and differential diagnosis with other causes of gastrointestinal symptoms and villous atrophy, as well as the differentiation between type I and II RCD, are complex, and may require specialized laboratories and reference hospitals. Immunosuppression is efficient in the milder RCDI; however, the treatment of RCDII falls short, with current options probably only providing transient clinical improvement and delaying EATL development. This review summarizes the current diagnostic and therapeutic approach for patients with RCD that all doctors that manage patients with CD should know.

References

Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders D, Cellier C . European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019; 7(5):583-613. PMC: 6545713. DOI: 10.1177/2050640619844125. View

Hussein S, Gindin T, Lagana S, Arguelles-Grande C, Krishnareddy S, Alobeid B . Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease. J Clin Pathol. 2018; 71(9):825-831. DOI: 10.1136/jclinpath-2018-205023. View

Nijeboer P, van Wanrooij R, van Gils T, Wierdsma N, Tack G, Witte B . Lymphoma development and survival in refractory coeliac disease type II: Histological response as prognostic factor. United European Gastroenterol J. 2017; 5(2):208-217. PMC: 5349358. DOI: 10.1177/2050640616646529. View

Al-Toma A, Visser O, van Roessel H, von Blomberg B, Verbeek W, Scholten P . Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood. 2006; 109(5):2243-9. DOI: 10.1182/blood-2006-08-042820. View

Therrien A, Silvester J, Leonard M, Leffler D, Fasano A, Kelly C . Enteric-Release Budesonide May Be Useful in the Management of Non-Responsive Celiac Disease. Dig Dis Sci. 2020; 66(6):1989-1997. PMC: 8515997. DOI: 10.1007/s10620-020-06454-5. View

Green P, Paski S, Ko C, Rubio-Tapia A . AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review. Gastroenterology. 2022; 163(5):1461-1469. DOI: 10.1053/j.gastro.2022.07.086. View

Mulder C, Wierdsma N, Berkenpas M, Jacobs M, Bouma G . Preventing complications in celiac disease: our experience with managing adult celiac disease. Best Pract Res Clin Gastroenterol. 2015; 29(3):459-68. DOI: 10.1016/j.bpg.2015.05.006. View

Verma A, Lionetti E, Gatti S, Franceschini E, Catassi G, Catassi C . Contribution of Oral Hygiene and Cosmetics on Contamination of Gluten-free Diet: Do Celiac Customers Need to Worry About?. J Pediatr Gastroenterol Nutr. 2018; 68(1):26-29. DOI: 10.1097/MPG.0000000000002129. View

Daum S, Wahnschaffe U, Glasenapp R, Borchert M, Ullrich R, Zeitz M . Capsule endoscopy in refractory celiac disease. Endoscopy. 2007; 39(5):455-8. DOI: 10.1055/s-2007-966239. View

10.

Tack G, Verbeek W, Al-Toma A, Kuik D, Schreurs M, Visser O . Evaluation of Cladribine treatment in refractory celiac disease type II. World J Gastroenterol. 2011; 17(4):506-13. PMC: 3027018. DOI: 10.3748/wjg.v17.i4.506. View

11.

Costantino G, Della Torre A, Lo Presti M, Caruso R, Mazzon E, Fries W . Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Dig Liver Dis. 2007; 40(1):74-7. DOI: 10.1016/j.dld.2006.10.017. View

12.

Schnedl W, Mangge H, Schenk M, Enko D . Non-responsive celiac disease may coincide with additional food intolerance/malabsorption, including histamine intolerance. Med Hypotheses. 2020; 146:110404. DOI: 10.1016/j.mehy.2020.110404. View

13.

Esteve M, Temino R, Carrasco A, Batista L, Del Val A, Ble M . Potential coeliac disease markers and autoimmunity in olmesartan induced enteropathy: A population-based study. Dig Liver Dis. 2015; 48(2):154-61. DOI: 10.1016/j.dld.2015.09.014. View

14.

Cellier C, Bouma G, van Gils T, Khater S, Malamut G, Crespo L . Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study. Lancet Gastroenterol Hepatol. 2019; 4(12):960-970. DOI: 10.1016/S2468-1253(19)30265-1. View

15.

Calado J, Verdelho Machado M . Celiac Disease Revisited. GE Port J Gastroenterol. 2022; 29(2):111-124. PMC: 8995660. DOI: 10.1159/000514716. View

16.

Rokkas T, Niv Y . The role of video capsule endoscopy in the diagnosis of celiac disease: a meta-analysis. Eur J Gastroenterol Hepatol. 2012; 24(3):303-8. DOI: 10.1097/MEG.0b013e32834fa914. View

17.

Verburg R, Toes R, Fibbe W, Breedveld F, van Laar J . High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review. Hum Immunol. 2002; 63(8):627-37. DOI: 10.1016/s0198-8859(02)00414-7. View

18.

Bagdi E, Diss T, Munson P, Isaacson P . Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood. 1999; 94(1):260-4. View

19.

Bergman D, Khalili H, Lebwohl B, Roelstraete B, Green P, Ludvigsson J . Celiac disease and risk of microscopic colitis: A nationwide population-based matched cohort study. United European Gastroenterol J. 2023; 11(2):189-201. PMC: 10039793. DOI: 10.1002/ueg2.12374. View

20.

Cellier C, Patey N, Mauvieux L, Jabri B, Delabesse E, Cervoni J . Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology. 1998; 114(3):471-81. DOI: 10.1016/s0016-5085(98)70530-x. View